Selected research
Industry Research
Oral COVID-19 Vaccine Industry Research Report 2026
Market perspective
The global Oral COVID-19 Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Oral COVID-19 Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Oral COVID-19 Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Oral COVID-19 Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Oral COVID-19 Vaccine include Shandong Xinhua Pharmaceutical, CanSino Biologics, Kintor Pharmaceutical, Pfizer, Zhejiang Huahai Pharmaceutical Co.,ltd., Henan Genuine Biotech Co., Ltd. and Kindred Biosciences, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Oral COVID-19 Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Oral COVID-19 Vaccine Market by Company
Shandong Xinhua Pharmaceutical
CanSino Biologics
Kintor Pharmaceutical
Pfizer
Zhejiang Huahai Pharmaceutical Co.,ltd.
Henan Genuine Biotech Co., Ltd.
Kindred Biosciences, Inc.
Oral COVID-19 Vaccine Segment by Type
Tablet Type
Inhalable Type
Oral COVID-19 Vaccine Segment by Application
Adults
Children
Elderly
Oral COVID-19 Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral COVID-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral COVID-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral COVID-19 Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Oral COVID-19 Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Oral COVID-19 Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Oral COVID-19 Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tablet Type
- Inhalable Type
Applications
- Adults
- Children
- Elderly
Companies covered
- Shandong Xinhua Pharmaceutical
- CanSino Biologics
- Kintor Pharmaceutical
- Pfizer
- Zhejiang Huahai Pharmaceutical Co.,ltd.
- Henan Genuine Biotech Co., Ltd.
- Kindred Biosciences, Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Oral COVID-19 Vaccine Market Size (2021-2032)
- 2.2.2 Global Oral COVID-19 Vaccine Sales (2021-2032)
- 2.2.3 Global Oral COVID-19 Vaccine Market Average Price (2021-2032)
- 2.3 Oral COVID-19 Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablet Type
- 2.3.3 Inhalable Type
- 2.4 Oral COVID-19 Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Adults
- 2.4.3 Children
- 2.4.4 Elderly
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Oral COVID-19 Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Oral COVID-19 Vaccine Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Oral COVID-19 Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Oral COVID-19 Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Oral COVID-19 Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Oral COVID-19 Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Oral COVID-19 Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Oral COVID-19 Vaccine, Established Date
- 3.9 Global Oral COVID-19 Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shandong Xinhua Pharmaceutical
- 4.1.1 Shandong Xinhua Pharmaceutical Company Information
- 4.1.2 Shandong Xinhua Pharmaceutical Business Overview
- 4.1.3 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shandong Xinhua Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
- 4.1.5 Shandong Xinhua Pharmaceutical Recent Developments
- 4.2 CanSino Biologics
- 4.2.1 CanSino Biologics Company Information
- 4.2.2 CanSino Biologics Business Overview
- 4.2.3 CanSino Biologics Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 CanSino Biologics Oral COVID-19 Vaccine Product Portfolio
- 4.2.5 CanSino Biologics Recent Developments
- 4.3 Kintor Pharmaceutical
- 4.3.1 Kintor Pharmaceutical Company Information
- 4.3.2 Kintor Pharmaceutical Business Overview
- 4.3.3 Kintor Pharmaceutical Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Kintor Pharmaceutical Oral COVID-19 Vaccine Product Portfolio
- 4.3.5 Kintor Pharmaceutical Recent Developments
- 4.4 Pfizer
- 4.4.1 Pfizer Company Information
- 4.4.2 Pfizer Business Overview
- 4.4.3 Pfizer Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Pfizer Oral COVID-19 Vaccine Product Portfolio
- 4.4.5 Pfizer Recent Developments
- 4.5 Zhejiang Huahai Pharmaceutical Co.,ltd.
- 4.5.1 Zhejiang Huahai Pharmaceutical Co.,ltd. Company Information
- 4.5.2 Zhejiang Huahai Pharmaceutical Co.,ltd. Business Overview
- 4.5.3 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Zhejiang Huahai Pharmaceutical Co.,ltd. Oral COVID-19 Vaccine Product Portfolio
- 4.5.5 Zhejiang Huahai Pharmaceutical Co.,ltd. Recent Developments
- 4.6 Henan Genuine Biotech Co., Ltd.
- 4.6.1 Henan Genuine Biotech Co., Ltd. Company Information
- 4.6.2 Henan Genuine Biotech Co., Ltd. Business Overview
- 4.6.3 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Henan Genuine Biotech Co., Ltd. Oral COVID-19 Vaccine Product Portfolio
- 4.6.5 Henan Genuine Biotech Co., Ltd. Recent Developments
- 4.7 Kindred Biosciences, Inc.
- 4.7.1 Kindred Biosciences, Inc. Company Information
- 4.7.2 Kindred Biosciences, Inc. Business Overview
- 4.7.3 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kindred Biosciences, Inc. Oral COVID-19 Vaccine Product Portfolio
- 4.7.5 Kindred Biosciences, Inc. Recent Developments
5 Global Oral COVID-19 Vaccine Market Scenario by Region
- 5.1 Global Oral COVID-19 Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Oral COVID-19 Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Oral COVID-19 Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Oral COVID-19 Vaccine Sales by Region: 2027-2032
- 5.3 Global Oral COVID-19 Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Oral COVID-19 Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Oral COVID-19 Vaccine Revenue by Region: 2027-2032
- 5.4 North America Oral COVID-19 Vaccine Market Facts & Figures by Country
- 5.4.1 North America Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Oral COVID-19 Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Oral COVID-19 Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Oral COVID-19 Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Oral COVID-19 Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Oral COVID-19 Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Oral COVID-19 Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Oral COVID-19 Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Oral COVID-19 Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Oral COVID-19 Vaccine Market Facts & Figures by Country
- 5.7.1 South America Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Oral COVID-19 Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Oral COVID-19 Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Oral COVID-19 Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Oral COVID-19 Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Oral COVID-19 Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Oral COVID-19 Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Oral COVID-19 Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Oral COVID-19 Vaccine Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Oral COVID-19 Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Oral COVID-19 Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Oral COVID-19 Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Oral COVID-19 Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Oral COVID-19 Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Oral COVID-19 Vaccine Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Oral COVID-19 Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Oral COVID-19 Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Oral COVID-19 Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Oral COVID-19 Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Oral COVID-19 Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Oral COVID-19 Vaccine Value Chain Analysis
- 8.1.1 Oral COVID-19 Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Oral COVID-19 Vaccine Production Mode & Process
- 8.2 Oral COVID-19 Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Oral COVID-19 Vaccine Distributors
- 8.2.3 Oral COVID-19 Vaccine Customers
9 Global Oral COVID-19 Vaccine Analyzing Market Dynamics
- 9.1 Oral COVID-19 Vaccine Industry Trends
- 9.2 Oral COVID-19 Vaccine Industry Drivers
- 9.3 Oral COVID-19 Vaccine Industry Opportunities and Challenges
- 9.4 Oral COVID-19 Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst